Accelerated market access for COVID-19 related devices

In response to the COVID-19 outbreak, many medical device market regulators are releasing Emergency Use Authorizations (EUAs) and expedited regulatory pathways for devices healthcare providers need most, including ventilators, face masks and PPE, and test kits, among others. Some authorities are reclassifying products to streamline market entry and avoid shortages. The situation is changing rapidly, and Emergo by UL is committed to monitoring these developments to deliver regulatory news and intelligence that helps medical device companies respond quickly to COVID-19. 

COVID-19 resources from Emergo

How we help

Emergo consultants are monitoring emergency use developments in markets affected by COVID-19. View all markets >

Medical Device and IVD Emergency Use Routes in Europe

In response to the COVID-19 outbreak, the EC has temporarily allowed the marketing of non-CE marked personal respiratory protective equipment, certain medical devices and IVDs, and biocides.

US FDA Emergency Use Pathways for Medical Devices and IVDs

The US FDA has declared the COVID-19 outbreak to be a public health emergency and invoked their authorities for Emergency Use Authorization (EUA), through which the FDA Commissioner may allow unapproved medical devices to be used for emergency applications.

Mexico Emergency Use Pathways for Medical Devices and IVDs

In light of the current COVID-19 emergency, COFEPRIS has published two official communications (March 26 and April 17) regarding its policies during this time, stating that all administrative terms and deadlines are to be stopped between March 26 and April 30, in order to deploy resources to perform essential functions related to COVID-19.

Remote Usability Testing Helps Ensure Effective Medical Device Use

A number of rapid, remote assessments, such as optimizing user interface, creating instructions for use, and usability test, can be performed to help ensure products are used safely and effectively.

Australia Emergency Use Pathways for Medical Devices

In response to the COVID-19 outbreak, the TGA has emergency exemptions that allow for the importation and sale of some devices, including COVID-19 IVD test kits, and products without the normal registration requirements, or expedited registrations, where applicable.

Mitigating Cybersecurity Risks in Emergency Situations

Medical device companies working to address COVID-19 need to mitigate cybersecurity risks associated with managing the outbreak.

Blog

Get the latest medical device regulatory news on COVID-19. View All

Jul 24, 2021

Taiwan update: Final exemption list, cybersecurity guidelines, COVID-19 measures and more

A fourth roundup of regulatory developments relating to Taiwan’s Medical Devices Act features the finalized...

READ MORE
Jul 14, 2021

US FDA guidelines for remote inspections of drug facilities: Implications for life sciences companies

Remote FDA inspections of drug facilities affecting life sciences companies' learning management and training needs

READ MORE
Jul 6, 2021

US FDA revokes Emergency Use Authorizations (EUA) for some personal protective equipment (PPE)

Latest FDA EUA revocations target non-NIOSH-approved respirators

READ MORE
Jul 1, 2021

Singapore HSA explains new developments for COVID-19 test kit authorizations

The regulatory body is no longer accepting provisional authorization (PA) applications for tests. It also...

READ MORE
Jun 22, 2021

Australian TGA removes discount for medical devices on Prostheses List

The Australian regulator is ending a measure intended to lessen the financial impact of elective...

READ MORE

COVID-19 resources

Get the most recent content from our resource library on COVID-19. View All